ALKBH5 and acute myeloid leukemia: T cell anti-tumor effects were evaluated using an AML cell and activated PBMC co-culture system.<h4>Results</h4>Bioinformatics analysis shows that ALKBH5 is significantly overexpressed in AML and is associated with poor prognosis and enrichment of immune related signaling pathways.